MECHANISMS OF GENOMIC REARRANGEMENT IN CARCINOGENESIS
Project Number5R29CA061935-02
Contact PI/Project LeaderBARR, FREDERIC G
Awardee OrganizationUNIVERSITY OF PENNSYLVANIA
Description
Abstract Text
The combined work of many investigators has demonstrated the importance of
genomic rearrangements in neoplastic development and has established that
environmental carcinogens can induce their formation. To analyze the
mechanism by which carcinogens induce genomic rearrangement, we have
developed a cell culture system in which the inactive endogenous thymidine
kinase gene in a hamster cell line is activated and rearranged by
carcinogen treatment. Our initial analysis of carcinogen-induced
rearrangements in the model cell culture system has suggested a potential
role for nuclear organization as well as DNA sequence in the rearrangement
process. To investigate the role of these mechanistic features in a human
cancer, we have identified the genes involved in the t(2;13) translocation
of the pediatric soft tissue tumor alveolar rhabdomyosarcoma. Furthermore,
we have developed PCR-based methodologies for isolating rearrangement
breakpoints and the associated wild-type rearrangement partners.
In the proposed project, we will employ several carcinogenic agents in our
cell culture system to isolate multiple independent clones with
rearrangements in the vicinity of the hamster thymidine kinase gene. The
distribution of breakpoints will be characterized by Southern blot, PCR,
and sequencing analyses. These experiments will thereby explore the
hypothesis that cancer-causing agents differ in their ability to cause
rearrangements. Following isolation of the rearrangement partners, the DNA
sequence, chromatin structure, methylation status, nuclear matrix
association, and genomic location of breakpoint regions will be examined
to test the hypothesis that both genetic and epigenetic features influence
the propensity of a region to rearrange. The findings from the cell
culture system will be compared to the structural features of the t(2; 13)
translocation breakpoints in the human cancer alveolar rhabdomyosarcoma.
Finally, PCR methodology will be applied to develop assays for
quantitation of the rearrangement frequency of a sequence in a population.
Such assays will permit exploration of rearrangement events at a variety
of genomic loci as well as evaluation of the role of specific
environmental and parental cell features in the rearrangement process by
directly manipulating components of the inducible system.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
DNA damageDNA footprintingDNA methylationalternatives to animals in researchcarcinogenesiscarcinogenschromatinchromosome translocationcomputer assisted sequence analysishuman genetic material taghuman tissuein situ hybridizationmethod developmentneoplasm /cancer geneticsnuclear matrixnucleic acid sequencepediatric neoplasm /cancerpolymerase chain reactionpulsed field gel electrophoresisrestriction mappingrhabdomyosarcomasouthern blottingthymidine kinasetissue /cell culture
No Sub Projects information available for 5R29CA061935-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R29CA061935-02
Patents
No Patents information available for 5R29CA061935-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R29CA061935-02
Clinical Studies
No Clinical Studies information available for 5R29CA061935-02
News and More
Related News Releases
No news release information available for 5R29CA061935-02
History
No Historical information available for 5R29CA061935-02
Similar Projects
No Similar Projects information available for 5R29CA061935-02